Serological Transplant Diagnostics Market
Serological Transplant Diagnostics Market Analysis By Product (Reagents & Accessories, Systems), By Application (Kidney, Liver, Heart, Lung Transplantation), By Distribution Channel & By Region - Global Market Insights 2021 to 2031
Analysis of Serological Transplant Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Serological Transplant Diagnostics Market Outlook (2021 to 2031)
The global serological transplant diagnostics market size is gaining traction and likely to ascend at around 2.5% CAGR during the forecast period of 2021 to 2031. While advancements in the medical & diagnostic sector are playing a vital role in raising the market value for serological transplant diagnostics, growing awareness regarding proper diagnosis remains another key growth factor.
The growth potential of the market will be propelled by mergers and acquisitions involving smaller specialized hospitals and Tier-1 hospitals. This trend is anticipated to enhance the value of the serological transplant diagnostics market over the predicted timeframe. Consequently, the demand for transplant diagnostic products, assays, and kits is expected to rise, driven by the increasing number of individuals seeking healthcare services from larger hospitals. These acquisitions also facilitate training opportunities for medical personnel, including physicians and nurses.
Regional players across North America, Europe, and Asia Pacific are set to witness impressive growth over the coming years, while rise in requirement from hospitals and other key distribution channels will further cater market growth in future.
A new study by Fact.MR provides thorough analysis of the global serological transplant diagnostics market, along with insights of key driving & restraining factors, demand-supply trajectories, and new trends around the globe for the forecast period of 2021 to 2031.
The report tracks the industry in 20+high-growth markets, and also details how the COVID-19 pandemic is shaping market growth.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Historical & Future Market Outlook
Serological transplant diagnosis, being a highly significant part of successful and efficient organ transplantation, has gained rapid traction over the past years.
Growth in key distribution channels such as hospitals and organ transplantation centers, to name a few, has further raised demand during the last 5 years from 2016 to 2020, which, in turn, has attracted more stakeholders to this industry.
Rise in cases of serious lung, liver, and kidney diseases, and medical & diagnostic advancements, are fuelling the sales of serological transplant diagnostic equipment.
Additionally, various initiatives taken by leading health organizations such as the WHO (World Health Organization), CDC (Centers for Disease Control and Prevention), and others are aiding the growth of suppliers in this industry.
According to Fact.MR, the global serological transplant diagnostics market is set to expand at around 2.5% CAGR through 2031.
How is Rising Need for Organ Transplants Aiding Demand for Serological Transplant Diagnostics?
Prevalence of organ damage cases has substantially raised the demand for serological transplant diagnostic solutions since the past decade. According to a report published by the National Kidney Foundation, over 2 million people across the world currently receive treatment for kidney failure, while a majority are treated in only five countries - the United States, Japan, Germany, Brazil, and Italy.
As per the report, more than 80% of all patients who receive treatment for kidney failure are from affluent countries, with universal access to healthcare and a large elderly population.
As stated in a report titled “The Burden of Lung Diseases”, published by the ERS Organization, respiratory diseases are among the leading causes of death worldwide, while lung infections, lung cancer, and chronic obstructive pulmonary disease (COPD) together account for approximately 10 million deaths yearly. This indicates the rising need serological transplant diagnostic equipment across regions.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Key Challenges Faced by Serology Transplant Diagnostic Equipment Suppliers?
While cases of kidney, heart, lung, and other organ damage are increasing steadily, there is still lack of knowledge and awareness regarding timely diagnosis and receiving proper treatment.
Furthermore, serological transplantation and diagnosis are quite expensive, and hence, not affordable by everyone.
As stated in a report published by NCBI, liver disease accounts for nearly 2 million deaths per year, worldwide. The fatality of liver, kidney, lung, and other organ damage is well-known, but still, organ transplants are yet to be widely adopted by patients who suffer from severe damage.
Manufacturers and suppliers of serological transplant diagnostics are investing their efforts to produce a broader range of affordable products as a solution to this issue.
Country-Wise Analysis
Why is the Serological Transplant Diagnostics Industry Anticipated to Exhibit Hegemony in the U.S.?
The United States is the leading country in North America as far as serological transplant diagnostics is concerned, and will witness impressive rise in demand over the coming years.
Highly advanced medical & diagnostic sectors coupled with rise in cases of severe kidney and heart diseases are fuelling the sales of manufacturers in the country.
As stated in a report titled “Heart Disease Facts”, published by CDC on 8th September 2020, heart disease cost the United States around US$ 219 billion each year from 2014 to 2015, which includes the cost of healthcare services, medicines, and lost productivity due to health.
As per the report, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States, and around 655,000 Americans die from heart disease, including heart damage, each year. As more people are becoming aware regarding the fatality of heart diseases, the rate of organ transplantation is rising in the U.S.
What Enables China to Maintain a Leading Market Position?
China, being the epicenter of the world’s fastest-growing market for serological transplant diagnostics, East Asia, is in the spotlight for manufacturers and suppliers in this industry.
Highly advanced diagnostics industry, and increase in cases of liver, kidney, and lung damage, are raising the revenue of players in in China.
As per data revealed by the China Governmental Statistical Survey, overall rate of survival in brain-dead donor single lung transplantation is more than 60%, while the same for double lung transplantation is more than 75%, as observed over the last 5 years.
This data gives a glimpse of new growth scope awaiting players dealing with serological transplant diagnostics in China.
How Lucrative Would Germany be for Providers of Serology Transplant Diagnostics?
Germany is the dominating country in Europe for serological transplant diagnostics, owing to surge in demand from highly developed hospitals and blood banks & transportation centers.
Additionally, rise in requirement in diverse applications such as liver transplantation, heart transplantation, and kidney transplantation is further catering to growth of the market.
According to a report published by the Germany Trade and Investment (GTAI) Organization, Germany’s healthcare market is number 1 in Europe by volume, number of patients, medical technology manufacturers, and healthcare providers. As per the report, Germany’s hospital industry is highly advanced, while healthcare spending in the country exceeded EUR 400 billion in 2019, and is growing further.
According to a report published by the PLOS Organization on 24th April 2020, in the adult German population, Chronic Kidney Disease (CKD) is estimated to have a prevalence between 2% to 7%, while a majority of CKD patients are classified as stage 3.
This is indirectly contributing to the rise in sales of serological transplant diagnostic equipment across the country.
Do Suppliers of Serological Transplant Diagnostic Equipment Need to Look at India?
India has emerged as another lucrative market for serological transplant diagnostics, and is expected to take its spot in the limelight for suppliers and manufacturers in this industry. Increase in cases of lung, heart, and kidney failure, coupled with steady growth of the healthcare & diagnostics industry is spurring growth in India.
According to a report titled “Chronic Kidney Disease in India”, published by the American Society of Nephrology on 7th May 2018, reported a prevalence of CKD in different regions across India ranges from 1% to 13%.
Recently, data from the International Society of Nephrology’s Kidney Disease Data Centre Study reported a prevalence of 17%, while the etiology of CKD varies considerably throughout India. These statistics give an idea regarding the upcoming opportunities in India for stakeholders in the serological transplant diagnostics space.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-Wise Insights
Which Product is Highly Sought-After for Serological Transplant Diagnostics?
According to Fact.MR, reagents & accessories, followed by systems, are dominating the global serological transplant equipment market in terms of product.
Reagents and accessories are an integral part of various types of serological transplant diagnostic tests such as blood type testing, Human Leukocyte Antigens (HLA) testing, and other serological tests, as they are highly useful and crucial for effective organ transplantation.
Which Transplantation Procedures Top the Application List?
Currently, rise in demand for serological transplant diagnosis is becoming more prevalent in applications such as kidney and liver transplantation. Increase in cases of kidney and liver damage is expected to further fuel the sales of manufacturers in this industry.
Some of the other key segments aiding market expansion in this category are heart and lung transplantation.
Rise in Demand from Hospitals to Bolster Market Growth
With steady expansion of hospitals, demand for serological transplant diagnostic equipment is surging around the globe. According to the European Commission (EC), the EU hospitals and healthcare industry is growing fast, while contributing to nearly 2% of EU’s total manufacturing workforce.
Other key distribution channels are blood banks & transplant centers, donor registries, and research laboratories.
Competitive Landscape
The global serological transplant diagnostics market is fragmented in nature and thriving on potential players. In order to capitalize on new opportunities, key market players are diversifying their product portfolios. For instance,
- Recently, Bag Health Care GmbH launched its wide range of serological transplant diagnostic solutions such as bag diagnostics microlymphocytotoxicity test, bag diagnostics histo trays, and others.
- Siemens Healthineers expanded its serological testing domains, including SARS-CoV-2 Testing in 2020, in order to increase its sales footprint.
Report Scope
| Attribute | Details |
|---|---|
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Middle East & Africa; Oceania |
| Key Countries Covered | US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
| Key Segments Covered | Product, Application, Distribution Channel, Region |
| Key Companies Profiled | Becton Dickinson & Company; ThermoFisher Scientific Inc.; Bio-Rad Laboratories Inc.; Agena Bioscience Inc.; Avioq Inc.; Bag Health Care GmbH; Immucor Inc.; Siemens Healthineers; Produkte GmbH |
| Report Coverage | Market Forecasts, Brand Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Market Segmentation by Category
-
By Product :
- Reagents & Accessories
- Systems
-
By Application :
- Kidney Transplantation
- Liver Transplantation
- Heart Transplantation
- Lung Transplantation
- Others
-
By Distribution Channel :
- Hospitals
- Blood Banks & Transplant Centres
- Donor Registries & Research Laboratories
-
By Region :
- North America
- Latin America
- Europe
- Middle East and Africa (MEA)
- East Asia
- South Asia
- Oceania
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Market Background
- 5. Market Context
- 6. Global Market Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 9. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Product
- 10.1. Reagents & Accessories
- 10.2. Systems
- 10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Application
- 11.1. Kidney Transplantation
- 11.2. Liver Transplantation
- 11.3. Heart Transplantation
- 11.4. Lung Transplantation
- 11.5. Others
- 11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Distribution Channel
- 12.1. Hospitals
- 12.2. Blood Banks & Transplant Centres
- 12.3. Donor Registries & Research Laboratories
- 12. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region
- 13.1. North America
- 13.2. Latin America
- 13.3. Europe
- 13.4. East Asia
- 13.5. South Asia
- 13.6. Oceania
- 13.7. Middle East and Africa (MEA)
- 13. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 14. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 15. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 16. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 17. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 18. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 19. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 20. Key and Emerging Countries Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 21. Market Structure Analysis
- 22. Competition Analysis
- 23.1. Beckman Coulter Inc.
- 23.3. Becton Dickinson & Company
- 23.4. ThermoFisher Scientific Inc.
- 23.5. Bio-Rad Laboratories Inc.
- 23.6. Agena Bioscience Inc.
- 23.7. Avioq Inc.
- 23.8. Bag Health Care GmbH
- 23.9. Immucor Inc.
- 23.10. Siemens Healthineers
- 23.11. Produkte GmbH
- 23. Assumptions and Acronyms Used
- 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Units) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Product
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 03: Global Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Application
Table 04: Global Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 05: Global Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Region
Table 06: North America Market Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 08: North America Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Application
Table 09: North America Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 10: Latin America Market Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 11: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 12: Latin America Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Application
Table 13: Latin America Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 14: Europe Market Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 15: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 16: Europe Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Application
Table 17: Europe Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 18: East Asia Market Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 20: East Asia Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Application
Table 21: East Asia Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 22: South Asia Market Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 23: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 24: South Asia Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Application
Table 25: South Asia Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 26: Oceania Market Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 27: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 28: Oceania Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Application
Table 29: Oceania Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Distribution Channel
Table 30: MEA Market Size (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 31: MEA Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Product
Table 32: MEA Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Application
Table 33: MEA Market Value (US$ Mn) Analysis- and Opportunity Assessment 2016 to 2031, By Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (Units), 2016 to 2020
Figure 02: Global Market Volume (Units) Forecast, 2021 to 2031
Figure 03: Serological Transplant Diagnostics, Pricing Analysis per unit (US$), in Global 2020
Figure 04: Serological Transplant Diagnostics, Pricing Forecast per unit (US$), in Global 2031
Figure 05: Global Market Value Analysis (US$ Mn), 2016 to 2020
Figure 06: Global Market Value Forecast (US$ Mn), 2021 to 2031
Figure 07: Global Market Absolute $ Opportunity, 2020 to 2031
Figure 08: Global Market Share Analysis (%), By Product, 2021 & 2031
Figure 09: Global Market Y-o-Y Analysis (%), By Product, 2021 to 2031
Figure 10: Global Market Attractiveness Analysis by Product, 2021 to 2031
Figure 11: Global Market Share Analysis (%), By Application, 2021 & 2031
Figure 12: Global Market Y-o-Y Analysis (%), By Application, 2021 to 2031
Figure 13: Global Market Attractiveness Analysis by Application, 2021 to 2031
Figure 14: Global Market Share Analysis (%), By Distribution Channel, 2021 & 2031
Figure 15: Global Market Y-o-Y Analysis (%), By Distribution Channel, 2021 to 2031
Figure 16: Global Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 17: Global Market Share Analysis (%) By Region, 2021 & 2031
Figure 18: Global Market Y-o-Y Growth (%) By Region, 2021 to 2031
Figure 19: Global Market Attractiveness Analysis by Region, 2021 to 2031
Figure 20: North America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 21: North America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 22: North America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 23: North America Market Attractiveness Analysis by Product, 2021 to 2031
Figure 24: North America Market Attractiveness Analysis by Application, 2021 to 2031
Figure 25: North America Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 26: Latin America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 27: Latin America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 28: Latin America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 29: Latin America Market Attractiveness Analysis by Product, 2021 to 2031
Figure 30: Latin America Market Attractiveness Analysis by Application, 2021 to 2031
Figure 31: Latin America Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 32: Europe Market Value Analysis (US$ Mn), 2016 to 2020
Figure 33: Europe Market Value Forecast (US$ Mn), 2021 to 2031
Figure 34: Europe Market Attractiveness Analysis by Country, 2021 to 2031
Figure 35: Europe Market Attractiveness Analysis by Product, 2021 to 2031
Figure 36: Europe Market Attractiveness Analysis by Application, 2021 to 2031
Figure 37: Europe Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 38: East Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 39: East Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 40: East Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 41: East Asia Market Attractiveness Analysis by Product, 2021 to 2031
Figure 42: East Asia Market Attractiveness Analysis by Application, 2021 to 2031
Figure 43: East Asia Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 44: South Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 45: South Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 46: South Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 47: South Asia Market Attractiveness Analysis by Product, 2021 to 2031
Figure 48: South Asia Market Attractiveness Analysis by Application, 2021 to 2031
Figure 49: South Asia Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 50: Oceania Market Value Analysis (US$ Mn), 2016 to 2020
Figure 51: Oceania Market Value Forecast (US$ Mn), 2021 to 2031
Figure 52: Oceania Market Attractiveness Analysis by Country, 2021 to 2031
Figure 53: Oceania Market Attractiveness Analysis by Product, 2021 to 2031
Figure 54: Oceania Market Attractiveness Analysis by Application, 2021 to 2031
Figure 55: Oceania Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 56: MEA Market Value Analysis (US$ Mn), 2016 to 2020
Figure 57: MEA Market Value Forecast (US$ Mn), 2021 to 2031
Figure 58: MEA Market Attractiveness Analysis by Country, 2021 to 2031
Figure 59: MEA Market Attractiveness Analysis by Product, 2021 to 2031
Figure 60: MEA Market Attractiveness Analysis by Application, 2021 to 2031
Figure 61: MEA Market Attractiveness Analysis by Distribution Channel, 2021 to 2031
Figure 62: US. Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 63: US. Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 64: US. Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 65: Global Vs. U.S. Growth Comparison
Figure 66: Canada Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 67: Canada Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 68: Canada Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 69: Global Vs. Canada Growth Comparison
Figure 70: Brazil Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 71: Brazil Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 72: Brazil Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 73: Global Vs. Brazil Growth Comparison
Figure 74: Mexico Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 75: Mexico Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 76: Mexico Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 77: Global Vs. Mexico Growth Comparison
Figure 78: Argentina Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 79: Argentina Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 80: Argentina Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 81: Global Vs. Argentina Growth Comparison
Figure 82: Germany Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 83: Germany Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 84: Germany Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 85: Global Vs. Germany Growth Comparison
Figure 86: Italy Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 87: Italy Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 88: Italy Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 89: Global Vs. Italy Growth Comparison
Figure 90: France Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 91: France Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 92: France Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 93: Global Vs. France Growth Comparison
Figure 94: U.K. Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 95: U.K. Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 96: U.K. Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 97: Global Vs. U.K. Growth Comparison
Figure 98: Spain Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 99: Spain Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 100: Spain Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 101: Global Vs. Spain Growth Comparison
Figure 102: BENELUX Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 103: BENELUX Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 104: BENELUX Market Value Share, By Distribution Channel, 2020 (E)
Figure 105: Global Vs. BENELUX Growth Comparison
Figure 106: Russia Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 107: Russia Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 108: Russia Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 109: Global Vs. Russia Growth Comparison
Figure 110: India Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 111: India Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 112: India Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 113: Global Vs. India Growth Comparison
Figure 114: Thailand Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 115: Thailand Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 116: Thailand Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 117: Global Vs. Thailand Growth Comparison
Figure 118: Malaysia Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 119: Malaysia Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 120: Malaysia Market Value Share, By Distribution Channel, 2020 (E)
Figure 121: Global Vs. Malaysia Growth Comparison
Figure 122: China Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 123: China Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 124: China Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 125: Global Vs. China Growth Comparison
Figure 126: Japan Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 127: Japan Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 128: Japan Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 129: Global Vs. Japan Growth Comparison
Figure 130: South Korea Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 131: South Korea Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 132: South Korea Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 133: Global Vs. South Korea Growth Comparison
Figure 134: Australia Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 135: Australia Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 136: Australia Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 137: Global Vs. Australia Growth Comparison
Figure 138: New Zealand Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 139: New Zealand Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 140: New Zealand Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 141: Global Vs. New Zealand Growth Comparison
Figure 142: GCC Countries Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 143: GCC Countries Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 144: GCC Countries Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 145: Global Vs. GCC Growth Comparison
Figure 146: Turkey Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 147: Turkey Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 148: Turkey Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 149: Global Vs. Turkey Growth Comparison
Figure 150: South Africa Market Value Share, By Product, 2021 (E) & 2031 (F)
Figure 151: South Africa Market Value Share, By Application, 2021 (E) & 2031 (F)
Figure 152: South Africa Market Value Share, By Distribution Channel, 2021 (E) & 2031 (F)
Figure 153: Global Vs. South Africa Growth Comparison
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
Which are the top companies operating in the market?
Some of the top companies providing serological transplant diagnostic equipment are Immucor Inc., Siemens Healthineers, Bio-Rad Laboratories Inc., and ThermoFisher Scientific Inc.
Which are some of the lucrative markets for serological transplant diagnostics?
The United States, Canada, China, Germany, The United Kingdom, Japan, France, and a few others are lucrative markets for serological transplant diagnostics, and are expected to dominate throughout the forecast period.
Which is a highly sought-after product for serological transplant diagnostics?
Presently, reagents & accessories are the mostly sought-after in terms of product, and are expected to keep leading over the forecast period as well.
Serological Transplant Diagnostics Market